Brown: Risk Weighti...
Health Care: Drugs
Hospira Inc. (HSP: NYSE)
$35.74 0.02 | 0.06%
05/17/13 - 04:01 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| HSP | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 22.69 | 9.77 | -32.40 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 0.90 | 0.05 | 0.02 |
| Net Income | 0.00 | 0.00 | |
| EPS | -0.89 | -0.52 |
Earnings for HSP:
| EBITDA | 369.70M |
| REVENUE | 4.09B |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $0.51 | $0.44 | $2.02 | $1.98 |
| Number of Analysts | 9 | 8 | 9 | 9 |
| High Estimate | $0.54 | $0.47 | $2.05 | $2.20 |
| Low Estimate | $0.49 | $0.42 | $1.98 | $1.37 |
| Prior Year | $0.51 | $0.47 | $2.01 | $2.02 |
| Growth Rate (Year over Year) | 0.44% | -5.59% | 0.55% | -2.03% |
Portfolios with HSP
- Portfolio NameUser Type
- Contributor8 Pharma Stocks to Watch
- ProRobert Bruce
- ProRonald Muhlenkamp
- UserFranks
- ContributorTop 20 Stocks With Large In...
- ProJohn Rogers - Ariel Capital...
- ContributorTheStreet Ratings Top-Rated...
- ContributorTop 20 Stocks With Huge Ins...
- UserAberian System, MEDICAL stocks
- Contributor5 Stocks Setting New 52-Wee...
Latest HSP Headlines from TheStreet
- Hospira Inc. (HSP): Today's Highlighted Laggard In Health Care 04.04.13 | 05:04 pm
- Hospira Inc. (HSP): Today's Featured Drugs Laggard 03.05.13 | 05:03 pm
- Hospira Rises On Unusually High Volume (HSP) 02.19.13 | 03:02 pm
- Hospira Stock Falls On Unusually High Volume (HSP) 02.13.13 | 11:02 am
- Cramer's 'Mad Money' Recap: The Benefit of Doing Nothing 10.08.12 | 08:10 pm
- Analysts' Actions: TOL PCLN CSCO AFL FRX 08.09.12 | 09:08 am
- Hospira Management Discusses Q2 2012 Results - Earnings Call Transcript 08.01.12 | 01:08 pm
- Hospira's CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.01.12 | 01:05 pm
- Hospira Management Discusses Q4 2011 Results - Earnings Call Transcript 02.14.12 | 12:02 pm
- UBS: 8 Pharma Stocks to Watch 01.20.12 | 12:01 pm
Press Releases for HSP
- Hospira Reappoints Dr. Sumant Ramachandra Chief Scientific Officer - PR Newswire 05.14.13 | 09:05 am
- Hospira Convenes Its 2013 Annual Meeting Of Shareholders - PR Newswire 05.08.13 | 12:05 pm
- Hospira Unveils Global Device Strategy - PR Newswire 05.01.13 | 07:05 am
- Hospira To Present At Upcoming Investor Conferences - PR Newswire 04.17.13 | 11:04 am
- Hospira Names Matthew R. Stober Senior Vice President Of Operations - PR Newswire 04.15.13 | 04:04 pm
- Hospira To Host Conference Call For First-Quarter 2013 Results - PR Newswire 04.02.13 | 10:04 am
- Hospira Obtains Six Months U.S. Pediatric Exclusivity For Precedexâ¿¢ (dexmedetomidine HCl) Injection - PR Newswire 03.18.13 | 10:03 am
- Hospira Announces Executive Changes - PR Newswire 03.01.13 | 02:03 pm
- Hospira To Present At Upcoming Investor Conferences - PR Newswire 02.05.13 | 10:02 am
- Hospira's TheraDocâ¿¢ Infection Control Assistant Ranked #1 In Its Category In The Latest "Best In KLAS" Report - PR Newswire 01.23.13 | 11:01 am
Partner Headlines for HSP
- Danish pension fund in Death Row protest - Financial Times 03.15.13 | 08:03 pm
- Rival's problems lift Hikma - Financial Times 03.14.13 | 01:03 am
- Watson Pharma Starts New Era As Generic Drug Titan - Investor's Business Daily 11.02.12 | 04:11 pm
- Hospira to Acquire Orchid Facility - Analyst Blog - NASDAQ 08.30.12 | 10:08 pm
- Hospira to Acquire Orchid Facility - Analyst Blog - Zacks 08.30.12 | 06:08 pm
- Rituxan And Its Biosimilar Competitors - Seeking Alpha 07.30.12 | 09:07 am
- Hospira Second Quarter Earnings Sneak Peek - Wall St. Cheat Sheet 07.27.12 | 02:07 am
- Dr. Reddy's & Merck Serono Team Up - Analyst Blog - Zacks 06.08.12 | 06:06 pm
- Significant Upside Of About 25% For Baxter, Covidien - Seeking Alpha 02.24.12 | 05:02 pm
- Biosimilars: The Next Big Thing - Analyst Blog - Zacks 01.13.12 | 05:01 pm
